Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum belumosudil concentrations in a patient receiving a combination of 3 gastric acid-suppressing agents: A case report. | Am J Health Syst Pharm | 2026 | 41058098 | PubTator, text mining | PubMed |
| A Review on Current Challenges and Emerging Therapies in Psoriasis Management. | Rev Recent Clin Trials | 2026 | 40990270 | PubTator, text mining | PubMed |
| In vitro axotomy models regulated by ROCK inhibitor for studying neuroregeneration and growth cone morphology. | Biomed J | 2026 | 40854379 | PubTator, text mining | PubMed |
| Reversal of MPPa-PDT Resistance in Osteosarcoma by Targeting ROCK2-Mediated Autophagy. | Cell Prolif | 2026 | 40670295 | PubTator, text mining | PubMed |
| Adeno-associated virus-mediated inhibition of ROCK2 promotes synaptogenesis and neurogenesis in rats after ischemic stroke. | Neural Regen Res | 2026 | 40537020 | PubTator, text mining | PubMed |
| The functional regulation of protein composite nanofibers on human astrocyte for neural regeneration. | Res Sq | 2025 | 41510265 | PubTator, text mining | PubMed |
| Molecular insights into treatment-resistant erectile dysfunction: staining patterns of human corpora cavernosa-a preliminary study. | Transl Androl Urol | 2025 | 41368254 | PubTator, text mining | PubMed |
| A new biocompatible amino-Gd-metallofullerenol (Amino-Gd-FulOH) nanoplatform as a potential MRI contrast agent and its effect on macrophages. | Biomed Pharmacother | 2025 | 41319518 | PubTator, text mining | PubMed |
| Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer. | Cells | 2025 | 41294859 | PubTator, text mining | PubMed |
| RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization. | Mol Cancer | 2025 | 41291745 | PubTator, text mining | PubMed |
| Activated protein C promotes human lung cancer progression through the release of tumor extracellular vesicles and transfer of microRNA-200a. | Cell Death Dis | 2025 | 41271627 | PubTator, text mining | PubMed |
| Triad of homocysteine, ROCK2 and vimentin as a convergent biomarker signature in pseudoexfoliation. | J Transl Med | 2025 | 41267096 | PubTator, text mining | PubMed |
| Rho kinase 2 promotes epithelial-mesenchymal transition and proliferation in human prostate cancer PC-3 cells. | J Pharmacol Sci | 2025 | 41241433 | PubTator, text mining | PubMed |
| Inhibition of nuclear ROCK2 by a novel thiourea derivative induces potent antitumor effects through PTEN/FOXO1 pathway restoration in prostate cancer. | Bioorg Chem | 2025 | 41232487 | PubTator, text mining | PubMed |
| Molecular Signature in Focal Cortical Dysplasia: A Systematic Review of RNA and Protein Data. | Int J Mol Sci | 2025 | 41155206 | PubTator, text mining | PubMed |
Real-world Canadian data on belumosudil therapy in heavily pretreated patients with steroid-refractory chronic graft-versus-host disease: treatment outcomes and risk factor analysis for failure-free survival. | Ann Hematol | 2025 | 41136748 | PubTator, text mining | PubMed |
| Brain-Bone Axis in Physiological and Pathological Conditions. | Int J Mol Sci | 2025 | 41097093 | PubTator, text mining | PubMed |
| Pharmacological evaluation of nanoformulated phloretin against myocardial ischemia with mechanistic validation via molecular docking and dynamics. | Eur J Pharmacol | 2025 | 41093225 | PubTator, text mining | PubMed |
| ROCK2 promotes renal cell carcinoma progression by functioning as an RNA-binding protein regulating the PAI-1/NLRP3 axis and senescence escape. | Cell Signal | 2025 | 41033616 | PubTator, text mining | PubMed |
| Integrated proteome, phospho-proteome and malonyl-proteome revealed a molecular alteration of breast cancer. | Sci Rep | 2025 | 41028821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=6